How the ATMP and cell and gene therapy industries can prepare to scale manufacturing operations safely, sustainably, and strategically.
Read MoreAllan Bream, MSChE
Senior Fellow - Biopharmaceutical Process
Raleigh, NC

Allan Bream has more than 35 years of engineering and manufacturing experience, including 30 years in the biotechnology industry. His expertise includes viral vector & cell therapy manufacturing facility design, large-scale bacterial fermentation & mammalian cell culture, vaccines, downstream processing, protein purification and Current Good Manufacturing Practice facility design, operations and assessment. Bream’s facilities experience includes all phases of process design, including master planning, conceptual and detailed design, construction services and equipment procurement across the United States, Puerto Rico, Europe and Asia. His experience also includes biosafety level 2 & 3 facility design projects. Bream has a Master of Science in biochemical engineering and a Bachelor of Science in chemical engineering from the University of Iowa.
Insights By Allan

Cell and gene therapy facility design molded by commercial biopharma experience
Interview with Niranjan Kulkarni, Senior Director, Allan Bream, Process Specialist, and Grace Linton, Process Architect at CRB that originally appeared in Cell and Gene Therapy Insights, on how commercial biopharma experience is shaping cell and gene therapy facility design.
Read More